| Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis S Moran, A Martínez-Cardús, S Sayols, E Musulén, C Balañá, ... The Lancet Oncology 17 (10), 1386-1395, 2016 | 448 | 2016 |
| Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications L Zammarchi, G Stella, A Mantella, D Bartolozzi, D Tappe, S Günther, ... Journal of Clinical Virology 63, 32-35, 2015 | 281 | 2015 |
| Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study TM Drake, AB Docherty, EM Harrison, JK Quint, H Adamali, S Agnew, ... American journal of respiratory and critical care medicine 202 (12), 1656-1665, 2020 | 221 | 2020 |
| Malignant pleural mesothelioma: history, controversy, and future of a man-made epidemic OD Røe, GM Stella Asbestos and Mesothelioma, 73-101, 2017 | 216 | 2017 |
| Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study) C Pinto, F Di Fabio, C Barone, S Siena, A Falcone, S Cascinu, ... British journal of cancer 101 (8), 1261-1268, 2009 | 215 | 2009 |
| Radiographic findings in 240 patients with COVID-19 pneumonia: time-dependence after the onset of symptoms SG Vancheri, G Savietto, F Ballati, A Maggi, C Canino, C Bortolotto, ... European radiology 30, 6161-6169, 2020 | 145 | 2020 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 136 | 2022 |
| Cancers of unknown primary origin: current perspectives and future therapeutic strategies GM Stella, R Senetta, A Cassenti, M Ronco, P Cassoni Journal of translational medicine 10, 1-11, 2012 | 134 | 2012 |
| Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses F Di Nicolantonio, S Arena, M Gallicchio, D Zecchin, M Martini, SE Flonta, ... Proceedings of the National Academy of Sciences 105 (52), 20864-20869, 2008 | 113 | 2008 |
| Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency I Ferrarotti, J Baccheschi, M Zorzetto, C Tinelli, L Corda, B Balbi, I Campo, ... Journal of Medical Genetics 42 (3), 282-287, 2005 | 111 | 2005 |
| Caveolin‐1 as a promoter of tumour spreading: when, how, where and why R Senetta, G Stella, E Pozzi, N Sturli, D Massi, P Cassoni Journal of cellular and molecular medicine 17 (3), 325-336, 2013 | 101 | 2013 |
| Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy E Cereda, A Turri, C Klersy, S Cappello, A Ferrari, AR Filippi, ... Cancer Medicine 8 (16), 6923-6932, 2019 | 99 | 2019 |
| Targeting EGFR in non-small-cell lung cancer: lessons, experiences, strategies GM Stella, M Luisetti, S Inghilleri, F Cemmi, R Scabini, M Zorzetto, E Pozzi Respiratory medicine 106 (2), 173-183, 2012 | 96 | 2012 |
| Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics GM Stella, M Luisetti, E Pozzi, PM Comoglio The lancet Respiratory medicine 1 (3), 251-261, 2013 | 89 | 2013 |
| Lung-seeking metastases GM Stella, S Kolling, S Benvenuti, C Bortolotto Cancers 11 (7), 1010, 2019 | 81 | 2019 |
| MET mutations in cancers of unknown primary origin (CUPs) GM Stella, S Benvenuti, D Gramaglia, A Scarpa, A Tomezzoli, P Cassoni, ... Human mutation 32 (1), 44-50, 2011 | 79 | 2011 |
| Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report M Ceruti, G Rodi, GM Stella, A Adami, A Bolongaro, A Baritussio, E Pozzi, ... Orphanet Journal of Rare Diseases 2, 1-7, 2007 | 70 | 2007 |
| Carbon nanotubes and pleural damage: perspectives of nanosafety in the light of asbestos experience GM Stella Biointerphases 6 (2), P1-P17, 2011 | 62 | 2011 |
| EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells GM Stella, R Scabini, S Inghilleri, F Cemmi, S Corso, E Pozzi, P Morbini, ... Journal of cancer research and clinical oncology 139, 1327-1335, 2013 | 61 | 2013 |
| Targeting the MET oncogene in cancer and metastases GM Stella, S Benvenuti, PM Comoglio Expert opinion on investigational drugs 19 (11), 1381-1394, 2010 | 52 | 2010 |
